Brief: Amarin Provides Update On VAZKEPA (Icosapent Ethyl) Intellectual Property Portfolio In Europe
03/04/2024 13:52
April 3 (Reuters) - Amarin Corporation PLC AMRN.O :
* AMARIN PROVIDES UPDATE ON VAZKEPA® (ICOSAPENT ETHYL)
INTELLECTUAL PROPERTY PORTFOLIO IN EUROPE
* AMARIN- GOT DECISION TO GRANT FROM EUROPEAN PATENT OFFICE
FOR
NEW PATENT COVERING VAZKEPA,EXTENDING VAZKEPA EXCLUSIVITY 8
ADDITIONAL YEARS INTO 2039
Source text for Eikon: ID:nGNXc9fB3V
Further company coverage: AMRN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Amarin
See all newsAmarin Corporation PLC reports results for the quarter ended June 30 - Earnings Summary
Ireland's Amarin Q2 revenue falls on lower licensing payments
Amarin Corporation PLC expected to post a loss of 1 cent a share - Earnings Preview
US Supreme Court backs generic drugmaker in 'skinny label' patent case (updated)
US Supreme Court backs generic drugmaker in 'skinny label' patent case